Capital Advisors Ltd’s Acadia Healthcare ACHC Stock Holding History

Capital Advisors Ltd’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Sell	8 -3	-27%	-$77	﹤0.01%	1334
2026 Q1	$0	Buy	+11	New	+$199	﹤0.01%	1329
2025 Q2	–	Sell	-271	Closed	-$8K	–	1308
2025 Q1	$8K	Buy	+271	New	+$10.3K	﹤0.01%	817
2024 Q2	–	Sell	-25	Closed	-$2K	–	1342
2024 Q1	$2K	Sell	25 -1	-4%	-$82	﹤0.01%	1009
2023 Q4	$2K	Buy	+26	New	+$1.93K	﹤0.01%	980
2023 Q2	–	Sell	-3	Closed	–	–	1258
2023 Q1	$0	Hold	3	–	–	﹤0.01%	1171
2022 Q4	$0	Hold	3	–	–	﹤0.01%	1171
2022 Q3	$0	Hold	3	–	–	﹤0.01%	1205
2022 Q2	$0	Buy	+3	New	+$209	﹤0.01%	956

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Capital Advisors Ltd's ACHC Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Acadia Healthcare (ACHC) stake by 27% in Q2 2026, selling an estimated $77 and leaving 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Capital Advisors Ltd first reported a position in ACHC in Q2 2022 and has held it in 9 quarters since. The position peaked at $8K in Q1 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Capital Advisors Ltd held 8 shares of Acadia Healthcare worth $0 as of Q2 2026.
Capital Advisors Ltd sold 3 Acadia Healthcare shares in Q2 2026, an estimated $77.
Acadia Healthcare made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1334 holding.
Capital Advisors Ltd first reported a position in Acadia Healthcare in Q2 2022 and has held it in 9 quarters since.
Capital Advisors Ltd's Acadia Healthcare position peaked at $8K in Q1 2025.
314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.